Berlusconi's vote gains hit euro; yen rebounds

NEW YORK: The strong election showing in Italy of former premier Silvio Berlusconi's party battered the euro Monday, amid worries a new coalition government could weaken Rome's commitment to reforms.

The euro rose in early trade amid the first exit polls from the two-day election, which suggested the center-left was on its way to a firm victory.

But later, data showed Berlusconi's party, and another rightist party, were neck-and-neck with rivals in the Senate race, suggesting it could end up part of a fractious coalition that could roll back Italy's deficit-cutting efforts.

At 2200 GMT, the euro was at $1.3065, down from $1.3189, after having risen to $1.3316 early in the day as European markets read the early poll results as keeping Berlusconi out of power.

Beyond Italy's election results, "the single currency remains poised to face additional headwinds over the near-term as the fundamental developments coming out of Europe point to a deepening recession," said David Song of DailyFX.

But commitment to the dollar was hanging on the testimony to Congress on Tuesday by Federal Reserve Chairman Ben Bernanke, with hopes he will clarify the Fed's direction amid some clear differences among policy-makers over how long to keep in place policies aimed at holding interest rates down.

Reports that the pro-stimulus Haruhiko Kuroda, currently head of the Asian Development Bank, would be nominated as Bank of Japan governor weakened the Japanese currency in early trade, with the dollar buying more than 94 yen.

But without official backup for those reports, the yen snapped back, the dollar dropping to 91.92 yen.

The euro also fell, to 120.12 yen from 123.18 late Friday.

"Mr. Kuroda's appointment would no doubt turn the BOJ policy to a much more accommodative stance," said Boris Schlossberg of BK Asset management.

"But the rally quickly fizzled... as there was no official confirmation from the government and traders took quick profits on the run-up."

The British pound held steady near where it dropped following Friday's sovereign downgrade by Moody's, which stripped London of its coveted AAA rating.

That sent the pound down to $1.5131, and on Monday it slipped beneath the $1.51 line before pulling back to trade at $1.5162 at 2200 GMT.

The dollar meanwhile rose to 0.9318 Swiss francs, compared to 0.9290 francs on Friday.

-AFP/ac

Read More..

94% women feel unsafe travelling alone in India, survey finds

NEW DELHI: The Delhi gang-rape incident has not just bruised the image of the national Capital, but the country as well. A travel survey has found that 94% women feel unsafe traveling alone, while 84% voted for Delhi as the most unsafe metro. The findings come at a time when an increasing number of women admitted that they preferred to travel alone both for work and leisure.

TripAdvisor, a leading travel site, surveyed 500 women to find that 84% women claimed to have travelled alone for leisure, business or both. The respondents were a mix of working women, including a number of self employed, as well as homemakers.

The survey also brings to light the disturbing fact that 94% women worry about their safety — always or at least sometimes — when they travel alone within India. Among women who said they travel alone on work, 37% agreed that they don't mind travelling alone but worry about their safety.

Even more dismal is the fact that more women travelers have a better sense of safety overseas than in India. Around 24% respondents said they worry when they travel within India but not when they travel to international destinations, while only 6% suggested otherwise.

Despite the fear and worry, only 33% women said they carry any item for self defense when travelling to a new or unfamiliar city.

Due to the recent spate of crime against women, Delhi has gained notoriety with 84% women claiming it to be the most unsafe metro in the country. Mumbai came out on top as the city considered safest by 34% women. Ahmedabad and Bangalore were tied at a distant second with 12% each.

Among the states, Delhi NCR again topped the hall of shame with 60% women voting it as the most unsafe. At a distant second is Bihar (18%), followed by Uttar Pradesh (8%). A majority of 27% respondents said they considered Maharashtra to be the safest state, followed by Gujarat (15%) and Karnataka (10%).

According to TripAdvisor country manager Nikhil Ganju, "The rise in women travelling alone on business is understandable fallout of the increase in the number of working women. The real surprise is the significant number of Indian women who are choosing to travel solo on vacation. Another interesting insight that highlights a latent opportunity for the hospitality sector is that 78% respondents said they would prefer to stay in an all women's hotel or on a women exclusive floor in a hotel, when travelling alone."

In a break from tradition, Indian women enjoy traveling alone for leisure. Among women who travel alone, 41% respondents said they actually enjoyed travelling alone for work. In addition, 76% said they enjoy going solo on holidays.

And lack of company is definitely not a complaint. In fact, majority (58%) said their biggest incentive for solo vacations was that they could do all the things they want without having to worry about what someone else wants. Around 34% women indicated they loved travelling alone as it was adventurous and exciting. Another 32% claimed the thrill of managing everything by themselves was a motivator as well.

Read More..

FDA approves new targeted breast cancer drug

WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.

The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a potent dose of anti-tumor poison.

Cancer researchers say the drug is an important step forward because it delivers more medication while reducing the unpleasant side effects of chemotherapy.

"This antibody goes seeking out the tumor cells, gets internalized and then explodes them from within. So it's very kind and gentle on the patients — there's no hair loss, no nausea, no vomiting," said Dr. Melody Cobleigh of Rush University Medical Center. "It's a revolutionary way of treating cancer."

Cobleigh helped conduct the key studies of the drug at the Chicago facility.

The FDA approved the new treatment for about 20 percent of breast cancer patients with a form of the disease that is typically more aggressive and less responsive to hormone therapy. These patients have tumors that overproduce a protein known as HER-2. Breast cancer is the second most deadly form of cancer in U.S. women, and is expected to kill more than 39,000 Americans this year, according to the National Cancer Institute.

The approval will help Roche's Genentech unit build on the blockbuster success of Herceptin, which has long dominated the breast cancer marketplace. The drug had sales of roughly $6 billion last year.

Genentech said Friday that Kadcyla will cost $9,800 per month, compared to $4,500 per month for regular Herceptin. The company estimates a full course of Kadcyla, about nine months of medicine, will cost $94,000.

FDA scientists said they approved the drug based on company studies showing Kadcyla delayed the progression of breast cancer by several months. Researchers reported last year that patients treated with the drug lived 9.6 months before death or the spread of their disease, compared with a little more than six months for patients treated with two other standard drugs, Tykerb and Xeloda.

Overall, patients taking Kadcyla lived about 2.6 years, compared with 2 years for patients taking the other drugs.

FDA specifically approved the drug for patients with advanced breast cancer who have already been treated with Herceptin and taxane, a widely used chemotherapy drug. Doctors are not required to follow FDA prescribing guidelines, and cancer researchers say the drug could have great potential in patients with earlier forms of breast cancer

Kadcyla will carry a boxed warning, the most severe type, alerting doctors and patients that the drug can cause liver toxicity, heart problems and potentially death. The drug can also cause severe birth defects and should not be used by pregnant women.

Kadcyla was developed by South San Francisco-based Genentech using drug-binding technology licensed from Waltham, Mass.-based ImmunoGen. The company developed the chemical that keeps the drug cocktail together and is scheduled to receive a $10.5 million payment from Genentech on the FDA decision. The company will also receive additional royalties on the drug's sales.

Shares of ImmunoGen Inc. rose 2 cents to $14.32 in afternoon trading. The stock has ttraded in a 52-wek range of $10.85 to $18.10.

Read More..

Pistorius' Brother Facing Own Homicide Trial

The attorney for Oscar Pistorius' family said today that the Olympian's brother is facing a culpable homicide charge relating to a 2008 road accident in which a motorcyclist was killed.

Carl Pistorius, who sat behind his younger brother, Oscar, every day at his bail hearing, will now face his own homicide trial for the accident five years ago, which his attorney, Kenny Oldwage, said he "deeply regrets."

Carl Pistorius is charged with culpable homicide, which refers to the unlawful negligent killing of another person. The charges were initially dropped, but were later reinstated, Oldwage said in a statement.

Full Coverage: Oscar Pistorius Case

Pistorius quietly appeared in court on Thursday, one day before his Paralympic gold-medalist brother was released on bail, Oldwage said. His next appearance is scheduled for the end of March.

Liza van Deventer/Foto24/Gallo Images/Getty Images

'Blade Runner' Murder Charges: Oscar Pistorius Out on Bail Watch Video

Oscar Pistorius Granted Bail in Murder Case Watch Video

It was the latest twist in a case that has drawn international attention, after 26-year-old Oscar Pistorius, a double amputee who ran in both the 2012 Olympic and Paralympic games, was charged with the premeditated murder of his model girlfriend, Reeva Steenkamp.

On Saturday, Carl Pistorius' Twitter handle was hacked, according to a family spokeswoman, prompting the Pistorius family to cancel their social media accounts.

Steenkamp's parents speak about the Valentine's Day shooting that ended their daughter's life in a sit-down interview on South African television tonight.

On Saturday, the model's father, Barry Steenkamp, told the Afrikaans-language Beeld newspaper that Pistorius will have to "live with his conscience" and will "suffer" if his story that he shot Steenkamp because he believed she was an intruder is false.

RELATED: Oscar Pistorius Case: Key Elements to the Murder Investigation

After a four-day long bail hearing, Pistorius was granted bail Friday by a South African magistrate.

The court set bail at about $113,000 (1 million rand) and June 4 as the date for Pistorius' next court appearance.

Pistoriuis is believed to be staying at his uncle's house as he awaits trial. As part of his bail conditions, Pistorius must give up all his guns, he cannot drink alcohol or return to the home where the shooting occurred, and he must check in with a police department twice a week.

Read More..

Syrian opposition says captures former nuclear site

AMMAN (Reuters) - Syrian rebels have captured the site of a suspected nuclear reactor near the Euphrates river which Israeli warplanes destroyed six years ago, opposition sources in eastern Syria said on Sunday.

Al-Kubar site, around 60 km (35 miles) west of the city of Deir al-Zor, became a focus of international attention when Israel raided it in 2007. The United States said the complex was a North Korean-designed nuclear reactor geared to making weapons-grade plutonium.

Omar Abu Laila a spokesman for the Eastern Joint Command of the Free Syrian Army said the only building rebels found at the site was a hangar containing at least one Scud missile.

"It appears that the site was turned into a Scud launch base. Whatever structures it had have been buried," he said, adding that three army helicopters airlifted the last loyalist troops before opposition fighters overran the area on Friday.

The Syrian military, which razed the site after the Israeli raid, said the complex was a regular military facility but refused to allow the International Atomic Energy Agency unrestrained access, after the agency said the complex could have been a nuclear site.

The U.N. investigation appears to have died down since the national revolt against Preident Bashar al-Assad broke out in 2011, with the armed opposition increasingly capturing military sites in rural areas and on the edges of cities.

U.N. inspectors examined the site in June 2008 but Syrian authorities has barred them access since.

Abu Laila said Scuds appear to have been fired from Kubar at rebel-held areas in the province of Homs to the west.

The complex, he said, had command and control links with loyalist troops in the city of Deir al-Zor, where Assad's forces have been on the retreat and are now based mainly in and around the airport in the south of the city.

Footage showed fighters inspecting the site and one large missile inside a hangar. One fighter pointed to what he said were explosives placed under the missile to destroy it before attacking forces got to it.

Abu Hamza, a commander in the Jafaar al-Tayyar brigade, said in a YouTube video taken at Kubar that various rebel groups, including the al Qaeda linked al-Nusra front, took part the operation and that U.N. inspectors were welcome to come and survey the site.

In the last few months, opposition fighters have captured large swathes of the province of Deir al-Zor, a Sunni Muslim desert oil producing region that borders Iraq, including most of a highway along Euphrates leading to Kubar.

The province is far from the Assad's main military supply bases on the coast and in Damascus. Long-time alliances between Assad, who belongs to the minority Alawite sect, an offshoot of Islam, and Sunni tribes in Deir al-Zor have also largely collapsed since the revolt.

But Assad's forces remain entrenched in the south of the city of Deir al-Zor and armed convoys guarded by helicopters still reach the city from the city of Palmyra to the southwest, according to opposition sources.

(Editing by Stephen Powell)

Read More..

Pakistan hit by nationwide blackout

ISLAMABAD: Pakistan was hit by a nationwide blackout for more than two hours after the breakdown of a major plant caused power stations to stop working across the country, officials said Monday.

While power cuts are common in Pakistan due to chronic underinvestment in infrastructure, outages across the whole country are rare.

Late Sunday's blackout occurred when the HUBCO plant in southwestern Baluchistan province, which generates 1,200 megawatts a day of electricity, developed a technical fault, said official Rai Sikandar.

That breakdown prompted a "cascading effect" which caused plants nationwide to shut down, said the water and power ministry official.

"It was a technical fault in one of our power plants and not in the national grid," he insisted, adding that electricity was gradually being restored across Pakistan after it remained off for more than two hours.

Another ministry official said power should be back on across the country within two hours.

He said that all 24 power stations in the capital Islamabad were working again and electricity was being restored in parts of all the country's four provinces.

"1,200 megawatts of electricity is back in the national grid with the restoration of different power stations," said the official.

He added an inquiry would look into the causes of the technical fault at HUBCO. "It would be pre-mature at this stage to speculate about the nature of the fault that caused the plant to fail."

- AFP/jc

Read More..

Riyaz Bhatkal: Shy student to terror mastermind

MUMBAI: Seventeen-year-old Riyaz Shahbandri from Kurla was a shy civil engineering student at Nagpada's Saboo Siddik polytechnic in 1993. He would maintain a low profile and hardly participated in any college events. However, girls found his chocolate-boy looks appealing. Two decades later, he began making headlines as Riyaz Bhatkal, a suspected terrorist who has killed more people than the feared Dawood Ibrahim or the hanged Pakistani terrorist Ajmal Kasab—more than 344 killed from 15 bomb blasts. Still elusive, today he is the most dreaded face of the banned terror outfit Indian Mujahideen.

Born in 1976 as Riyaz Ismail Shahbandri in Bhatkal village of Karnataka, he came to be known as Roshan Jamal, while staying at the 60-year-old, two-storey building Qadir Mansion in Kurla here. Today his family owns two rooms in the building, which have been rented out as they wanted to stay away from the police who would often land up at their place inquiring about his whereabouts. His father, Ismail, had shifted from Karnataka to Mumbai for setting up a purse-making business much before Riyaz was born. Despite obtaining a degree in civil engineering, Riyaz couldn't find a job and began helping his father in his business. By then, his elder brother Iqbal had joined a local developer's firm as a civil engineer.

In 2001, Riyaz fell in love with a girl from Kurla but his family disapproved of the relationship and he was finally married to Nashua, the daughter of a Bhatkal-based businessman. A few months before his wedding, he came in touch with the Kurla unit of Students' Islamic Moment of India (SIMI). When he became a member of the outfit, it was already divided into two factions, extremists and the moderates. Riyaz preferred to stay with the first group. While the outfit was banned and its members arrested, he managed to evade the police. Soon he started preaching the SIMI ideology and was considered as a key figure among his associates. At the same time, Riyaz came in touch with local goons and started extorting money from traders in order to fund the activities of SIMI. "In 2002, he allegedly gave supari to kill the owner of Deepak Farsan in Kurla. The shooters killed the owner's bodyguard and Riyaz was never arrested," said an investigator of the case.

A city crime branch official said, "A year later, he entered Pakistan illegally and got training in operating fire arms and assembling explosives at a Lashkar-e-Taiba (LeT) camp. In 2004, along with Atif Ameen (who was later killed in the Batla House encounter in 2008), Sadiq Asrar Shaikh (who is behind bars in Mumbai), Subhan Qureishi alias Tauqeer and Yasin Bhatkal (both absconding), he conducted his first training for Indian men at Jolly Beach, a farm house in Bhatkal. Yasin, though hailing from Bhatkal, is not related to Riyaz. In 2005, the quintet executed their first terror blast at Sankat Mochan temple in Uttar Pradesh. While Riyaz provided the explosives, Tauqeer and Shaikh recruited the men. This was the time the group decided to name itself Indian Mujahideen (IM). Cops were unaware of its existence. Iqbal too had got influenced by the extremist ideology. He was one of the founder members of the IM.

"Soon after executing the bombings at the court premises in Lucknow, Varanasi and Faizabad on November 23, 2007, IM sent its first email to a news channel, claiming responsibility," the charge sheet on these blasts reads. In 2008, IM carried out bombings in Bangalore and Ahmedabad and for the first time Riyaz's name cropped up during the probe. He had conducted a seven-day training session for new recruits at Bhatkal prior to the blasts." After police started visiting Bhatkal frequently in search of him, Riyaz escaped to Pakistan in 2008 via Bangladesh. That was the last time his family saw him," a senior ATS officer added. Meanwhile, his father was last spotted in Mumbai on April 16, 2008, when he had gone to collect rent for his two rooms in Qadir Mansion.

In March 2010, Riyaz travelled to Colombo and met Yasin Bhatkal, Mohsin Chaudhry and Mirza Himayat Bain to plan Pune's German Bakery bomb blast. In July 2011, a red corner notice was issued against Riyaz in connection with the 2008 Bangalore blast. The chargesheet in Mumbai's July 13, 2011, triple blast cases said that "the entire criminal conspiracy was hatched by Riyaz and Yasin Bhatkal", who are "the chief cogs of the notorious" IM. The banned terrorist group, it adds, was created by Pakistani spy agency ISI "to spread terror in India". Riyaz and his brother Iqbal Bhatkal "operate from Pakistan" and impart instructions via electronic means to their associates based here through Yasin. According to forensic reports, Trinitrotoluene (TNT), ammonium nitrate and petroleum oil were used in the Mumbai bomb blasts.

This is the story as narrated by Riyaz's proteges, neighbors, friends and police. However, no one knows Riyaz's side of the story.

Riyaz Bhatkal's bloody trail:

Oct 29, 2005: Paharganj, Sarojini Nagar and Gopal Nagar in Delhi, killed 62

March 7, 2006: Sankat Mochan temple, Kashi Viswanath temple in Varanasi, killed 28

Nov 24, 2006: Faizabad, Lucknow and Varanasi courts

May 25, 2007: Gorakhpur market

Aug 25, 2007: Lumbini Park and Gokul Chat in Hyderabad, killed 42

May 23, 2008: Jaipur, killed 80

July 24, 2008: Bangalore, killed 02

July 25, 2008: Ahmedabad serial explosions, killed 56

July 26, 2008: Surat (bombs defused)

Sept 13, 2008: Delhi, killed 30

Feb 13, 2010: Pune German Bakery blast, killed 17

July 13, 2011: Mumbai triple blasts, killed 27

August 1, 2012: Pune serial bomb blasts

Total killed: 344

Read More..

FDA approves new targeted breast cancer drug

WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.

The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a potent dose of anti-tumor poison.

Cancer researchers say the drug is an important step forward because it delivers more medication while reducing the unpleasant side effects of chemotherapy.

"This antibody goes seeking out the tumor cells, gets internalized and then explodes them from within. So it's very kind and gentle on the patients — there's no hair loss, no nausea, no vomiting," said Dr. Melody Cobleigh of Rush University Medical Center. "It's a revolutionary way of treating cancer."

Cobleigh helped conduct the key studies of the drug at the Chicago facility.

The FDA approved the new treatment for about 20 percent of breast cancer patients with a form of the disease that is typically more aggressive and less responsive to hormone therapy. These patients have tumors that overproduce a protein known as HER-2. Breast cancer is the second most deadly form of cancer in U.S. women, and is expected to kill more than 39,000 Americans this year, according to the National Cancer Institute.

The approval will help Roche's Genentech unit build on the blockbuster success of Herceptin, which has long dominated the breast cancer marketplace. The drug had sales of roughly $6 billion last year.

Genentech said Friday that Kadcyla will cost $9,800 per month, compared to $4,500 per month for regular Herceptin. The company estimates a full course of Kadcyla, about nine months of medicine, will cost $94,000.

FDA scientists said they approved the drug based on company studies showing Kadcyla delayed the progression of breast cancer by several months. Researchers reported last year that patients treated with the drug lived 9.6 months before death or the spread of their disease, compared with a little more than six months for patients treated with two other standard drugs, Tykerb and Xeloda.

Overall, patients taking Kadcyla lived about 2.6 years, compared with 2 years for patients taking the other drugs.

FDA specifically approved the drug for patients with advanced breast cancer who have already been treated with Herceptin and taxane, a widely used chemotherapy drug. Doctors are not required to follow FDA prescribing guidelines, and cancer researchers say the drug could have great potential in patients with earlier forms of breast cancer

Kadcyla will carry a boxed warning, the most severe type, alerting doctors and patients that the drug can cause liver toxicity, heart problems and potentially death. The drug can also cause severe birth defects and should not be used by pregnant women.

Kadcyla was developed by South San Francisco-based Genentech using drug-binding technology licensed from Waltham, Mass.-based ImmunoGen. The company developed the chemical that keeps the drug cocktail together and is scheduled to receive a $10.5 million payment from Genentech on the FDA decision. The company will also receive additional royalties on the drug's sales.

Shares of ImmunoGen Inc. rose 2 cents to $14.32 in afternoon trading. The stock has ttraded in a 52-wek range of $10.85 to $18.10.

Read More..

Fiery Last-Lap Daytona Crash Injures 15 Fans

A fiery last-lap crash at the Daytona International Speedway injured a number of spectators today, who were seen being carried away from the stands on stretchers.

Fifteen spectators were taken to the hospital, according to ESPN, with one on the way to surgery with head trauma.

The 12-car crash happened moments before the end of the Nationwide race, and on the eve of the Daytona 500, one of NASCAR's biggest events.

The crash was apparently triggered when driver Regan Smith's car, which was being tailed by Brad Keselowski on his back bumper, spun to the right and shot up the track. Smith had been in the lead and said after the crash he had been trying to throw a "block."

Rookie Kyle Larson's car slammed into the wall that separates the track from the grandstands, causing his No. 32 car to go airborne and erupt in flames.

When a haze of smoke cleared and Larson's car came to a stop, he jumped out uninjured.

His engine and one of his wheels were sitting in a walkway of the grandstand.

"I was getting pushed from behind," Larson told ESPN. "Before I could react, it was too late."

Driver Michael Annett was taken to the hospital after he slammed head-on into a barrier during the chaos. NASCAR officials told ESPN the driver was awake and alert.

Tony Stewart pulled out the win, but in victory lane, what would have been a celebratory mood was tempered by concern for the injured fans.

"We've always known this is a dangerous sport," Stewart said. 'But it's hard when the fans get caught up in it."

Read More..

Berlusconi slams Europe's 'lords of austerity'

ROME: Italy's Silvio Berlusconi on Saturday said Europe's "lords of austerity" had tried to get rid of him, speaking in apparent breach of rules for candidates to stay silent the day before elections.

"I contradicted the lords of austerity who are now trying to get rid of me," Berlusconi was quoted by the ANSA news agency as saying in Milan in an interview with Greek television.

Leftist candidate Antonio Ingroia asked for sanctions against the billionaire tycoon but Berlusconi's office said the interview had been given only with the explicit agreement that it be released on Monday after polls close.

The comments were then widely quoted by Italian media.

In the interview, the scandal-tainted Berlusconi said outgoing prime minister Mario Monti was "subservient and always on his knees in front of Mrs Merkel (German Chancellor Angela Merkel) and now she does not want to lose him".

"The same thing would happen with (centre left leader and poll favourite Pier Luigi) Bersani. But I would give her a run for her money," he said.

"Austerity increases the public debt and lead to a recessionary spiral that pushes up unemployment and can result in the loss of social calm," he added.

Berlusconi, who is currently a defendant in two trials for tax fraud and for having sex with an underage prostitute, also said prosecutors were "a worse mafia than the Sicilian mafia".

Italians take to the polls on Sunday and Monday, Berlusconi expected to come a close second after Bersani.

- AFP/jc

Read More..